Rupinder Dhillon

Energetic healthcare professional with diverse experience in Emergency Medicine, Urgent Care, Correctional Medicine, Primary Care, Geriatrics & Skilled Nursing Facility, Addiction Medicine, and Psychiatry. Constantly seeking new opportunities to provide care for critical patients, vulnerable/special populations, and behavioral issues. Possesses knowledgeable clinical decision-making skills and a commitment to evidence-based practices. Proactive and diligent collaborator, completed an accredited Physician Assistant Program and Medical School. Known for attention to detail, open-mindedness, and ability to demonstrate understanding and patience.

• Rescue Mission of Syracuse
• Amaus Health Service at The Cathedral of Immaculate Conception, Syracuse
• Red Cross

• CITI Good Clinical Practice
• CPR Certification
• ACSL Certification
• BLS Certification
• PALS Certification
• HIPPA Certification
• NYS Infection Control Training
• Data Management Series for Research
• Training in Identification of Reporting of Child Abuse and Maltreatment
• Death Certificate Training
• Weight Loss Training
• DEA-X (MAT Certificate-100 pts.)
• Management of Pain
• Approach to Acutely Ill Patients
• Coronavirus Education Certificate
• Ethical and Psychosocial Issues in Management of COVID-19
• Compliance Certificates
• EPIC/ TechCare/ 10e11

• Gulani, Vikas, MD, PhD. Assessment of MRI Technology - Retrospective Chart Review quantitative MRI, chart review
• Tarr, Robert W. MicroVention Low Profile Visualized Intraluminal Support or LVIS Jr. Humanitarian use device. MicroVention LVIS HDE
• Tarr, Robert W .Humanitarian Use Device: The Wingspan Stent System with Gateway PTA Balloon Catheter
• Sunshine, Jeffrey. Emergency Use of ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM
• Sunshine, Jeffrey .CODMAN ENTERPRISE Vascular Reconstruction Device and Delivery System approved under Humanitarian Device Exemption (HDE) H060001
• Paspulati, Raj Mohan, MD. Retrospective evaluation of the clinical characteristic associated with patient claustrophobia during MRI examination.
• Gilkeson, Robert C. Evaluation of Dual-Energy Digital Radiography for the Detection of Cardiothoracic Diseases Evaluation of Dual-Energy Digital Radiography
• Gulani, Vikas, MD, PhD. Assessment of advanced Imaging techniques in the evaluation and management of prostate cancer and correlation of imaging findings with clinical findings and patient outcomes Advanced Imaging and Prostate Cancer
• Gulani, Vikas, MD, PhD. Assessment of Magnetic Resonance Fingerprinting (MRF) for predicting tumor response after neoadjuvant chemo radiation therapy in rectal cancer and colorectal cancer metastasis to liver
• Gulani, Vikas, MD, PhD. Copy of Assessment of MRI Technology - Retrospective Chart Review Quantitative MRI, chart review
• Gulani, Vikas, MD, PhD. Development of Magnetic Resonance Imaging Technology Development MRI Technology
• Gulani, Vikas, MD, PhD. Minimal Data Requirements for Accurate MRI Diagnosis of Liver Lesions Hepatic MRI Data Reduction
• Gulani, Vikas, MD, PhD Assessment of novel MRI quantification free breathing technique in evaluation of liver lesions MRI, liver, biopsy
• Gulani, Vikas, MD, PhD. Quantitative MR Angiography and Perfusion (MRAP) Imaging for Assessing Disease Status and Treatment in Peripheral Arterial Disease
• Abouassaly, Robert. Novel Screening MRI for the Detection of Prostate Cancer Screening, MRI, Pro
• Jones, Robert S, Ohio . NaF PETMRI evaluation for bone metastases in Breast Cancer bone, cancer, and radiology
• Paspulati, Raj Mohan, MD. Retrospective study comparing prostate MRI for transitional zone carcinomas to surgical specimen histopathological findings.
• Landeras, Luis. Data Collection for Philips CAD Regulatory Clearance Philips CAD Validation
• Haaga, John. Immuno-histochemical Staining of Archived tissue biopsy samples Immuno-histochemical Staining of Archived tissue biopsy samples
• Robbin, Mark R. Non-Delay iMRA versus traditional iMRA and non-contrast MRI in evaluation of glenoid labrum Non-Delay iMRA
• Nakamoto, Dean A, MD. Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated with Pancreatic Cancer Percutaneous Cryoablation
• Gilkeson, Robert C. Preliminary assessment of the added diagnostic value of post processed detector-based dual energy Computed Tomography (DECT) images using data acquired on the Spectral Detector Computed Tomography (SDCT) preliminary assessment detector dual-energy CT, image post-processing
• Rajiah, Prabhakar, MD. Comparison of the image quality between a single energy CT scanner and the conventional images from a Spectral scanner Conventional CT vs SDCT
• Avril, Norbert. MR Acquisition Optimization and Validation in Volunteers MRI (of PET/MRI) on normal volunteers
• Robbin, Mark R. Simulation-Based Interventional Education Curriculum Radiology, interventional, simulation
• Tarr, Robert W. Humanitarian Use Device: The Neuroform TM Microdelivery EZ Stent System Neuroform, Micro Delivery, stent
• Sunshine, Jeffrey. Radiology workflow efficiency
• Gilkeson, Robert C. Retrospective review of incidental lung nodules detected during coronary artery calcium scoring test with MDCT incidental , pulmonary, coronary
• Sunshine, Jeffrey. Anatomical Linking for Improved Reading Efficiency of Radiological Images Radiology, Reading, Image registration
• Gilkeson, Robert C. Computer Aided Detection of Lung Cancer with Dual Energy Digital Radiography CAD of Lung CA with Dual Energy
• Nakamoto, Dean A, MD. Image Guided sclerotherapy for treatment of vascular anomalies. sclerotherapy, vascular malformation, lymphatic malformation
• Robbin, Mark R. Long-Term Follow-Up of Osteoid Osteoma after treatment with radiofrequency ablation Osteoid Osteoma follow-up
• Robbin, Mark R. Comparison of diagnostic accuracy between using Bonopty Bone Biopsy Kits versus using Laurane Bone Biopsy Kits. Bone Biopsy Accuracy
• Robbin, Mark R .Copy of Non-Delay iMRA versus traditional iMRA and non-contrast MRI in evaluation of glenoid labrum; Non-Delay iMRA
• Phase I, A Randomized, Double Blind, Placebo Controlled, Ascending Dose Study to Evaluate the Safety and Efficacy of CEP-37247 Administered at Single Doses of 0.5, 1,3,6, or 12mg by the Transforaminal Epidural Route for the Treatment of Patients with Lumbosacral Radicular Pain Associated with Disk Herniation.
• Phase 3, A 12 Week, Randomized, Double Blind, Placebo Controlled Study of Asimadoline in Subjects with Diarrhea- Predominant Irritable Bowel Syndrome. (D-IBS)
• Phase 2, A Multicenter, Randomized, Double Blind, Placebo Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients with Primary Fibromyalgia.
• Phase 3, A Multicenter, Randomized Active Control Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities.
• Phase 3, A Randomized, Double Blind, Placebo Controlled, Multicenter Trial with an Enriched Study Design to Assess the Efficacy and Safety of Oxycodone/ Naloxone Controlled release Tablets (OXN) Compared to Placebo in Opioid experienced Subjects with Moderate to Severe Pain due to Chronic Low Back Pain who Required Around the Clock Opioid Therapy.
• Phase 3, A Randomized, Double Blind, Placebo Controlled, Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea- Predominant Irritable Bowel Syndrome.
• Phase 3, Randomized, Double Blind, Parallel Group study to Evaluate the Efficacy and safety of once daily oral administration of BI 10773 25mg/ linagliptin 5mg and BI 10773 10mg/ linagliptin 5mg Fixed Dose Combination tablets compared with the individual Component for 52 weeks in treatment naïve and metformin treated patient with type 2 diabetes mellitus with insufficient glycemic control.
• Phase 3, A Randomized, Double Blind, Placebo Controlled, multidose, pivotal study to determine the efficacy and safety of SST 0225, a topical ibuprofen cream, in the treatment of pain associated with acute ankle sprain.
• A 14 Week Randomized Parallel Group Placebo-Controlled Double-Blind Multicenter Study Of Fesoterodine 8 Mg In Overactive Bladder Patients With Sub-Optimal Response To Tolterodine 4 Mg Extended Release (ER)
• A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
• “Title of Project : A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma'
• MK-3475-051: A Phase I/II Study of MK-3475 (Pembrolizumab) in Children with advanced melanoma or a PD-L1 positive advanced, relapsed, or refractory solid tumor or lymphoma
• Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients with a recent Embolic Stroke of Undetermine